Unobio
1 known investors
Unobio is a biotech company running drug discovery programs that begin with patient data and validate candidates against patient biology at each stage, aiming to improve translation rates from preclinical work to clinical trials. Its approach targets the failure of programs that clear in vitro and animal models but fail in later-stage clinical phases.
Investors · 1
Competitors · 3
by search overlap
AviadoBio Website9 shared keywordsAviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
bio6 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
IQVIA5 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Companies competing with Unobio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Unobio do?
- Unobio is a biotech company running drug discovery programs that begin with patient data and validate candidates against patient biology at each stage, aiming to improve translation rates from preclinical work to clinical trials. Its approach targets the failure of programs that clear in vitro and animal models but fail in later-stage clinical phases.
- Who are Unobio's investors?
- Unobio's investors include Focal Ventures.